A fascinating conundrum in cell signaling is how stimulation of the same receptor tyrosine kinase with distinct ligands generates specific outcomes. To decipher the functional selectivity of EGF and TGF-a, which induce epidermal growth factor receptor (EGFR) degradation and recycling, respectively, we devised an integrated multilayered proteomics approach (IMPA). We analyzed dynamic changes in the receptor interactome, ubiquitinome, phosphoproteome, and late proteome in response to both ligands in human cells by quantitative MS and identified 67 proteins regulated at multiple levels. We identified RAB7 phosphorylation and RCP recruitment to EGFR as switches for EGF and TGF-a outputs, controlling receptor trafficking, signaling duration, proliferation, and migration. By manipulating RCP levels or phosphorylation of RAB7 in EGFR-positive cancer cells, we were able to switch a TGF-a-mediated response to an EGF-like response or vice versa as EGFR trafficking was rerouted. We propose IMPA as an approach to uncover fine-tuned regulatory mechanisms in cell signaling.
Cells respond to extracellular signals through transmembrane receptors, such as receptor tyrosine kinases (RTKs). However, how core signaling cascades are orchestrated by different RTKs to elicit distinct cellular responses is still under debate. Signaling specificity can be modulated by rewiring overlapping protein networks 1 , proteinprotein interactions 2 , and differences in signal duration 3 . The spatiotemporal distribution of RTKs in distinct subcellular compartments has also been associated with signaling specificity 4, 5 . For instance, the tight control of the endosomal distribution of activated EGFR 6 and the dichotomy between receptor degradation in lysosomes and receptor recycling to the plasma membrane have been shown to affect signaling outputs [7] [8] [9] [10] . Differential endocytic sorting of RTKs is now considered to be a fundamental process regulating signaling duration and thus long-term responses 11 . Consequently, studying the molecular basis of RTK trafficking has implications for understanding diseases such as cancer that are caused by aberrant RTK signaling or derailed endocytosis 12 .
The concept of functional selectivity is well established for G-proteincoupled receptors 13 . However, this phenomenon has scarcely been explored in the context of RTKs, although a better knowledge of RTK selectivity may aid in designing improved therapeutic drugs 14 . Using quantitative proteomics, we have recently reported that FGFR2b trafficking, signaling duration, and responses are dictated by the ligand 9 , but it remains to be determined whether these characteristics can be generalized to other ligand-RTK pairs. To systematically examine how ligands affect RTK signaling, we focused on EGFR and its ligands epidermal growth factor (EGF) and tumor growth factor alpha (TGF-α), which induce differential sorting of the internalized receptor 15, 16 . However, to our knowledge, their cellular effects have not previously been compared.
As an alternative to multiparametric image analysis or genetic screens combined with data-driven statistics 17, 18 , we performed a time-resolved analysis of EGFR signaling by using MS-based quantitative proteomics, a powerful technology for large-scale analysis of complex and dynamic signaling networks [19] [20] [21] [22] . We developed IMPA, an integrated multilayered proteomics approach that combines different layers of information (interactome, phosphoproteome, ubiquitinome, and late proteome), with functional assays to provide insights into the molecular mechanisms underlying EGFR responses. Thus, we analyzed the dynamic cross-talk between phosphorylation and ubiquitination, the most prominent post-translational modifications (PTMs) regulating receptor signaling, trafficking, and cellular outcomes 23 , in response to two distinct EGFR ligands. Our comprehensive analysis represents a powerful resource that expands upon previous proteomics studies focusing on single aspects of the EGFR signaling enigma [24] [25] [26] [27] . We also demonstrated the strength of this multidisciplinary approach in decoding functional selectivity and highlighting key regulatory-protein hubs by identifying RAB7 tyrosine phosphorylation and recruitment of RAB coupling protein (RCP, also known as RAB11FIP1) to EGFR as ligand-dependent molecular switches, which determine EGFR trafficking and outputs in human cancer cell lines.
RESULTS

Integrated multilayered proteomics dissects EGFR signaling
To study the functional selectivity of RTKs, we focused on EGFR stimulated with 100 ng/mL EGF or TGF-α, by using the epithelial cervix carcinoma cell line HeLa, which expresses moderate levels of EGFR and is suitable for proteomics, signaling, and trafficking studies. We chose this ligand concentration because it triggered maximum receptor phosphorylation after 2 min ( Supplementary  Fig. 1a) , thus ensuring that the observed differences between ligands were not due to partial EGFR activation. This concentration is beyond the physiological levels of EGF and TGF-α in different body fluids and organs 28 .
Analyzing EGFR trafficking by confocal microscopy 8 , we observed that hemagglutinin (HA)-tagged EGFR accumulated in the cytoplasm of cells stimulated for 8 or 40 min and was recycled back to the cell surface after 90 min (Fig. 1a,b) . However, in agreement with results from previous studies 16, 29 , TGF-α induced 91% EGFR recycling, whereas EGF treatment resulted in only partial EGFR recycling (22%). We confirmed these results by colocalization studies with EEA1 or GFPtagged versions of RAB5, RAB7, and RAB11, which are established markers of early, degradation, or recycling endosomes, respectively 8 . Endogenous EGFR was present in RAB5-and EEA1-positive early endosomes after 8 min of stimulation with either ligand (Fig. 1c,d and Supplementary Fig. 1b ). At this time point, most of the receptor was active, as demonstrated by recognition by an antibody detecting phosphorylated EGFR tyrosine 1068 (Y1068), a marker of EGFR activation 6 (Supplementary Fig. 1c,d) . At 40 min, however, EGFR displayed preferential accumulation in RAB7-or in RAB11-positive compartments, depending on EGF or TGF-α stimulation, respectively (Fig. 1c,d) ; this result indicated ligand-dependent differences in receptor degradation and recycling. EGFR remained phosphorylated on Y1068 at 40 min after stimulation with TGF-α but not EGF, and we also observed active EGFR at the plasma membrane after 90 min of treatment with TGF-α ( Supplementary Fig. 1c,d) . Together, these findings suggest that under our experimental conditions, TGF-α induced the internalization and recycling of active EGFR, whereas after stimulation with EGF, EGFR was active in early endosomes but disappeared between 40 and 90 min. Accordingly, we confirmed that TGF-α was a stronger mitogen than EGF 30 (Fig. 1e,f) .
To analyze the molecular link between ligand-dependent early events (for example, receptor trafficking) and long-term outcomes, we used a multilayered and time-resolved quantitative proteomics approach (Online Methods and Supplementary Fig. 2a ) to analyze cell lysates after stimulation with EGF or TGF-α for 1, 8, 40, or 90 min, or 72 h. We collected information on the EGFR interactome, tyrosine and serine/threonine phosphoproteome, ubiquitinome, and late proteome ( Fig. 2a and Supplementary Tables 1-4) . We assessed the quality of our MS data on the basis of the high degree of reproducibility 
between two independent experiments for all five data sets, and the identification of peptides with high mass accuracy and in the highintensity range ( Supplementary Fig. 2b-d) . We analyzed samples from cells stimulated with EGF or TGF-α for 1-90 min for changes in phosphorylation and ubiquitin levels, and we found 5,541 phosphorylated and 1,311 ubiquitinated sites mapping to 1,949 and 782 proteins, respectively (class I sites; Fig. 2b, Supplementary Fig. 2e , and Supplementary Tables 1 and 2) . Of the 5,541 phosphorylated sites, 457 (8%) were tyrosine phosphorylated ( Supplementary Fig. 2f ), thus indicating an enrichment of tyrosine-phosphorylated proteins in our samples. Most of the PTM-modified peptides were singly phosphorylated or singly ubiquitinated ( Supplementary Fig. 2g,h ), a result in line with those from previous studies 9, 31 . We deemed sites to be regulated if their stable isotope labeling by amino acids in cell culture (SILAC) ratios were increased to more than two in at least one experimental condition (Online Methods). We found 1,257 regulated phosphorylation sites (22.6%), 225 regulated ubiquitinated sites (17%) and more than half of all identified tyrosine-phosphorylated sites (259 of 457), results supporting the crucial involvement of tyrosine phosphorylation in EGFR responses 26 (Fig. 2b) . For the receptor interactome analysis, we performed immunoprecipitation of endogenous EGFR, by using lysates from the same cells described above. We identified 855 proteins, of which 40 were dynamically recruited to EGFR at at least two time points (Fig. 2b, Supplementary Fig. 2a , and Supplementary Table 3 ; definition of 'EGFR interactor' in Online Methods). To analyze the changes in the late proteome, we focused on the 72-h time point and identified 5,926 proteins, of which 223 showed substantial changes in abundance after treatment (referred to as 'regulated') ( Fig. 2b and Supplementary Table 4) . By integrating the five data sets, we covered 76.6% (7,047 proteins) of the known proteome of HeLa cells 32 , of which 14.7% (1,036 proteins) were regulated ( Fig. 2b and Supplementary Table 5) . We reasoned that central protein hubs in the EGFR network incorporate multilevel signals and would therefore be regulated on several levels. Therefore, we prioritized proteins that were regulated in more than one data set and short-listed 67 proteins, of which 30 were specifically regulated after EGF stimulation and 15 after TGF-α stimulation (Fig. 2c) . Several proteins known to be involved in EGFR trafficking (EPS15, CAV1, and RAB7) 33 were regulated by both phosphorylation and ubiquitination only in EGF-treated cells (Fig. 2c) . Another protein npg r e s o u r c e involved in endocytosis, RCP 34 , was not PTM regulated, but TGF-α treatment increased both the abundance of this protein and its dynamic interaction with EGFR (Fig. 2c) . These findings suggest that the two ligands control EGFR trafficking through different mechanisms.
EGFR was the only protein regulated in all four data sets by both EGF and TGF-α (Fig. 2c) . Confirming the MS-based quantification of the total EGFR levels by western blotting (WB), we observed that EGF treatment resulted in EGFR degradation between 40 and 90 min, whereas TGF-α treatment induced receptor stabilization after 90 min of stimulation, a result consistent with receptor recycling ( Figs. 1 and 2d-f , and Supplementary  Fig. 1b-d) . We also found, both in the phosphoproteome and by quantification of WB analysis, that TGF-α stimulation led to sustained ERK signaling, in contrast to the transient ERK phosphorylation in response to EGF (Fig. 2d-f) . ERK phosphorylation was not detectable in cells treated with the specific EGFR inhibitor AG1478, thus confirming that the response to both ligands was mediated by EGFR (Fig. 2e-f) . The dose of ligands affected neither the level of EGFR nor the dynamics of ERK phosphorylation (Fig. 2g) . Collectively, these data indicate that TGF-α-mediated stabilization of active EGFR influences signaling duration and that each ligand-EGFR pair uses specific mechanisms for the control of receptor endocytosis, thus resulting in distinct cellular outcomes.
Biased ligands specifically regulate PTMs
To obtain insights into the molecular mechanisms underlying the differential responses generated by EGF and TGF-α, we analyzed the distribution of regulated sites and EGFR interactors over time. The number of regulated tyrosine-phosphorylated sites was highest at 1 min, followed by regulated ubiquitinated sites at 8 min, and regulated serine/threonine phosphorylation sites at 40 min. We found the highest number of proteins interacting with EGFR after 1 min of stimulation with both EGF and TGF-α (Fig. 3a) , results similar to those for the regulation of phosphorylated tyrosine. Principal component analysis (PCA) showed a clear separation of early and late time points and indicated that the results for the 8-min time point were the most divergent between EGF and TGF-α in all data sets (Fig. 3b) , thus suggesting that signaling activated at 8 min is stimulus specific.
Gene Ontology (GO) enrichment analysis of the six temporal profiles (clusters) based on fuzzy c-means clustering of 330 regulated phosphorylated and 52 regulated ubiquitinated sites revealed that biological processes, such as proliferation, migration, and endocytosis, were enriched after stimulation with either EGF or TGF-α ( Supplementary Fig. 3a,b) . However, considering both the temporal pattern and the total amplitude of the PTM changes (defined by the similarity parameter S score 35 ), EGF and TGF-α regulated phosphorylation in a similar way but regulated ubiquitination differentially ( Supplementary Fig. 3c ). Together with a difference in the number of ubiquitinated sites in cluster 6 (recycling responders) in favor of TGF-α, this finding suggests that TGF-α enhanced cellular ubiquitination. Enriched GO terms of ubiquitinated sites included signaling and ubiquitin-mediated activity but also long-term cellular events, such as DNA repair and protein folding (Supplementary Fig. 3c ). npg r e s o u r c e on kinases and phosphatases ( Fig. 4a) . We found 260 proteins that were both phosphorylated and ubiquitinated, and 25 of these were regulated at the level of both PTMs ( Fig. 4b and Supplementary  Tables 1 and 2 ). GO enrichment analysis of the regulated doubly versus singly modified proteins showed enrichment not only of signaling and endocytic processes (for example, EGFR, EPS15, RAB7, and ERBB2) but also of long-term responses such as metabolism and proliferation (for example, HSPD1, HUWE1, TRIM28, and EIF3B) ( Fig. 4c,d and Table 1 ). This result was consistent with a broader role of PTMs, particularly ubiquitination in cellular processes. We analyzed ligand-dependent regulation of these 25 doubly modified proteins and found that EGF treatment mainly induced phosphorylation at early time points (1-8 min), whereas TGF-α treatment resulted in sustained phosphorylation of the same proteins and in prolonged ubiquitination of several proteins ( Supplementary Fig. 4 ). Overall, these data confirmed that phosphorylated and ubiquitinated proteins involved in signaling, trafficking and downstream processes have opposite temporal profiles in response to the two EGFR ligands.
EGFR degradation depends on RAB7 phosphorylation on Y183
To assess the power of IMPA to uncover candidates mediating RTK functional selectivity, we focused on endocytic proteins regulated on multiple levels after stimulation with either EGF or TGF-α, because these two ligands induce opposite intracellular fates of EGFR (Figs. 1 and 2c, and Supplementary Fig. 1b-d ). One such candidate indicated by IMPA was RAB7, a known marker of late endosomes deregulated in several diseases 39, 40 . EGF, after 72 h of stimulation, doubly modified RAB7 at early time intervals without affecting its total levels ( Table 1 , based on the STRING database and visualized with Cytoscape (ClusterONE plugin). Cluster 1, P = 7 × 10 −6 ; cluster 2, P = 0.049 (one-tailed Mann-Whitney U test). EGFR and RAB7A are highlighted in orange and blue, respectively.
Of the 66 enriched proteins (79 PTM sites) differentially regulated by the two ligands, 54 had more than one ubiquitinated site, and TGF-α specifically regulated 27 proteins (28 sites) ( Supplementary  Fig. 3d ). Interestingly, we found that the ubiquitination sites of 20 TGF-α-regulated proteins belonging to sustained temporal profiles (three out of six clusters) were static after EGF stimulation (cluster 0) ( Supplementary Fig. 3a,d and Supplementary Table 2) , thus strengthening the idea that TGF-α, compared with EGF, induced sustained ubiquitination in our experimental conditions (Fig. 3a) . TGF-α also regulated the chaperone protein BagAG1 and the ubiquitinconjugating enzyme UBE2T, which is involved in DNA repair 36, 37 , in the proteome ( Supplementary Fig. 3d and Fig. 2c ), thus suggesting a previously unknown link between TGFα-induced ubiquitination, sustained signaling, and long-term responses. Next, we analyzed the dynamic regulation of the phosphoproteome. First, we compared the dynamic EGFR tyrosine phosphoproteome with the FGFR2b tyrosine phosphoproteome previously measured in the same cell line 9 . PCA separated the two tyrosine phosphoproteomes (Fig. 3c) , thus suggesting that each ligand-RTK pair affects signaling duration and specificity in a unique way. Second, to identify protein kinases activated downstream of EGFR, we searched for enriched amino acid residues adjacent to the regulated phosphorylation sites. The results indicated that TGF-α favored a proline in the position immediately C terminal to the phosphorylation site (Fig. 3d) , a feature of many ERK substrates. We also observed that TGF-α, but not EGF, mediated prolonged activation of ERK up to 72 h after stimulation (Fig. 3e,f) .
Finally, we studied the cross-talk between phosphorylation and ubiquitination after EGFR activation by comparing the number of modified kinases, phosphatases, ubiquitin E3 ligases, and deubiquitinating enzymes (DUBs), representing the writers and erasers of these two PTMs 38 . Kinases (especially tyrosine kinases) and phosphatases were more phosphorylated than ligases and DUBs when compared to the phosphorylation level of the expressed HeLa proteome 32 (Fig. 4a and Supplementary Tables 1 and 2) . Although writers and erasers were mainly modified by the PTMs that they regulate, there was also an extensive cross-talk between the two PTM systems, with a slightly higher phosphorylation on ligases and DUBs compared with ubiquitination r e s o u r c e induced the phosphorylation of RAB7 on Y183 twice as strongly as did TGF-α (Fig. 5b) . Changes in RAB7 phosphorylation might affect RAB7 ubiquitination or its interaction partners. The RAB7 mutant and WT showed equal ubiquitination in the absence of any stimulus, and there was a slight downregulation after stimulation and a more pronounced decrease after 40 min of treatment with EGF ( Fig. 5b and  Supplementary Table 2) . We next stimulated cells transfected either with WT or mutant RAB7 with EGF for 8 min and then immunoprecipitated GFP-tagged RAB7 (Supplementary Fig. 6a ). From two independent experiments showing good correlation ( Supplementary  Fig. 6b) , we confirmed the similar ubiquitination pattern on WT and mutant RAB7 after 8 min of EGF stimulation ( Supplementary  Fig. 6c-e) . These data point to a complex interplay between PTMs on RAB7. Furthermore, we found 15 endocytosis-related proteins specifically interacting with the RAB7 mutant compared with the WT (Supplementary Fig. 6f ). Among these were signaling proteins, such as GRB2 and PI3K, members of clathrin pits (CLTCL1, AP1B1, and EPS15L1), the early endosome marker RAB5, and a protein associated with recycling (RABEP1) 33 . We therefore hypothesized that proteins binding to RAB7 Y183F but not to WT RAB7 may affect EGFR trafficking after EGF stimulation. In cells stimulated with EGF for 40 min, EGFR was present in RAB7-positive compartments in WT cells, and in recycling vesicles marked by the transferrin receptor (Tf-R) 9 in RAB7 Y183F-expressing cells (Fig. 5c,d) . This finding suggests that in the presence of EGF, the level of Y183 phosphorylation on RAB7 at 8 min acts as a molecular switch determining EGFR fate at later time points (40 min), probably by inducing the detachment of RAB7 from a specific set of endocytic proteins. This effect did not depend on cellular delocalization of the RAB7 mutant compared with RAB7 WT (Fig. 5d) , and it was EGF specific, because the majority of TGF-α-stimulated EGFR was still in Tf-R-positive vesicles in both WT and mutant RAB7 cells (Fig. 5c,d) . These data also indicate that RAB7 Y183 phosphorylation did not affect TGF-α-dependent receptor recycling. Furthermore, we observed EGF-induced receptor stabilization and sustained ERK activation in the presence of RAB7 Y183F but not in WT cells, whereas the TGF-α-dependent prolonged response was not affected by the mutant RAB7 (Figs. 2e and 5e) . Collectively, these results indicate a link between ligand-dependent receptor recycling and signaling duration 8, 9, 29 .
Next, we verified the effect of RAB7 Y183 phosphorylation on cell proliferation in HeLa cells and other human cancer cell lines of different origin. In the presence of WT RAB7, all the tested cell lines exhibited less proliferation after stimulation with EGF than with TGF-α (Figs. 1e,f and 5f, and Supplementary Fig. 6g ). However, EGF-and TGF-α-stimulated proliferation occurred to a similar extent in cells transfected with RAB7 Y183F (Fig. 5f) , thus suggesting that EGF-mediated EGFR stabilization and recycling in the absence of RAB7 phosphorylation were crucial for the magnitude of the downstream response.
Overall, these results indicate that EGF-mediated phosphorylation of Y183 on RAB7 acts as a molecular switch priming EGFR for degradation and ultimately affecting signaling duration and long-term responses. EGF stimulation resulted in EGFR ubiquitination and in the recruitment of the known E3 ligase CBL-B to the activated receptor ( Supplementary Fig. 7a-c and Fig. 6a,b) . This ubiquitination marks the receptor for degradation, as previously established 33, 41, 42 . Therefore, our data suggest that RAB7 phosphorylation is as important as EGFR ubiquitination in controlling receptor degradation.
RCP mediates TGF-a responses
Under our experimental conditions, TGF-α induced sustained EGFR ubiquitination as well as prolonged phosphorylation of the CBL-familybinding site Y1045 and of the GRB2-binding site Y1068 on EGFR 42 ( Supplementary Fig. 7a-c and Fig. 6a,b) . Furthermore, after stimulation with TGF-α and EGF, EGFR showed the highest phosphorylationsite occupancy (defined as the fraction of phosphorylation at a given site) 43 for the peptide containing Y1045 and Y1068 ( Supplementary  Fig. 7d) . Finally, TGF-α promoted the recruitment of CBL-B, GRB2, and SHC to EGFR with different kinetics (Supplementary Fig. 7a-c and Fig. 6a,b) . These data together indicate full receptor activation after exposure to both stimuli. In contrast with EGF, TGF-α did not result in tyrosine phosphorylation of hepatocyte growth factorregulated tyrosine kinase substrate (HRS; also known as HGS), another event required for EGFR degradation 44 ( Supplementary Fig. 7e and Supplementary Table 1) . Because TGF-α did not regulate RAB7 phosphorylation to the same extent as EGF (Fig. 5) , we hypothesized that TGF-α-mediated EGFR trafficking occurred because TGF-α promoted the binding to the receptor of proteins belonging to the recycling pathway. Thus, we analyzed the interactome data set for ligand-selective EGFR interactors (Supplementary Table 3 and Online 
Methods). We found a strong network of proteins centered on EGFR, which could be divided into two groups. The first one encompassed 26 EGF-dependent EGFR interactors, including canonical RTK players (GRB2, CBL, SHC, VAV2, PI3K, SOS, and PLCγ; Fig. 6c) . Some of these proteins were also modified by PTMs and showed the same kinetics of regulation after EGF treatment (Supplementary Tables 1  and 2 , and Supplementary Fig. 7f ). The second group of EGFR interactors included 16 TGF-α enriched proteins comprising the cell-cycle regulator CDC23, the adaptor DVL3, and proteins involved in vesicle transport (RCP and RAB6A; Fig. 6c ). Immunoprecipitation and subsequent WB analysis demonstrated that TGF-α, but not EGF, induced the persistent formation of the EGFR-GRB2-RCP complex or the EGFR-GRB2-DVL3 complex ( Fig. 6d and Supplementary  Fig. 7g,h) . The sustained binding of GRB2 to the receptor was consistent with sustained phosphorylation of the GRB2-binding site Y1068 on EGFR after TGF-α stimulation ( Supplementary Fig. 7a and Fig. 6a,b) . These findings validated the interactome data and supported the idea that TGF-α facilitates the recruitment of unique proteins to EGFR. TGF-α promoted prolonged phosphorylation of most of the analyzed tyrosine sites on EGFR compared with EGF ( Supplementary Fig. 7a and Fig. 6a ). This kinetic result was similar to that of binding of GRB2, CBL-B, and RCP to EGFR (Fig. 6b-d) , to the total EGFR levels, and to downstream ERK activation (Fig. 2e-g ). Therefore, TGF-α stimulation triggers the activation of unique signaling proteins. We focused on RCP because this RAB11 effector has previously been associated with integrin-mediated EGFR endocytosis 34 . In addition, TGF-α, but not EGF, regulated RCP in both the interactome and proteome data sets (Fig. 2c) . TGF-α-mediated EGFR trafficking and signaling duration changed in cells depleted of RCP with short interfering RNA (siRNA) compared with cells transfected with control siRNA. EGFR was present in RAB11-and RCP-positive regions in WT cells stimulated with TGF-α for 40 min (Fig. 6e,f) . However, the receptor was present in RAB7-positive compartments in the absence of RCP after stimulation with either EGF or TGF-α (Fig. 6e,f) . Furthermore, in cells depleted of RCP and stimulated with TGF-α, EGFR stability decreased, thus resulting in transient ERK phosphorylation (Fig. 6g) . These data suggest that RCP is a molecular switch for EGFR recycling and signaling in response to TGF-α. RCP bound to RAB11 and RAB5 after stimulation with TGF-α, but not EGF, for 8 min (Fig. 6h) , thus indicating that the fast recruitment of RCP to RAB5-positive early endosomes primed EGFR for recycling under our experimental conditions. These data also support the idea that the early 8-min time point is crucial for the regulation of trafficking and signaling upon each stimulus (Figs. 3b, 5 and 6) .
Next, we showed by WB that RCP protein levels were higher after treatment with TGF-α than with EGF, whereas RAB7 levels were unaffected in lysates from HeLa cells and three other human cancer cell lines, thus confirming our observations in the proteome data set (Figs. 2c and 7a,b) . Because GO-term analysis showed an enrichment of intracellular signaling and migration in cells stimulated with TGF-α for 72 h (Fig. 7a) , we addressed whether long-term ERK activation r e s o u r c e and cell migration depended on RCP. In cancer cell lines depleted of RCP and stimulated for 24-72 h with TGF-α, ERK phosphorylation was absent, and cell proliferation was decreased compared with that in WT cells (Fig. 7b,c) . Furthermore, TGF-α did not induce cell migration in the absence of RCP (Fig. 7d) . Conversely, EGF still activated ERK after 24 h but not 72 h of stimulation, and it induced cell proliferation and migration in both RCP-depleted and WT cells (Fig. 7b-d) . RCP is therefore required for TGF-α-but not EGFdependent long-term responses in several human cancer cells.
DISCUSSION
This study provides a comprehensive resource quantifying temporal changes in EGFR responses after stimulation with two ligands inducing differential receptor trafficking (Fig. 8) . Sequential analysis of changes in the EGFR interactome, phosphoproteome, ubiquitinome, and late proteome by MS-based quantitative proteomics, an approach here defined as IMPA, revealed EGF-and TGF-α-specific mechanisms for the regulation of EGFR endocytic routes, signaling, and long-term outputs. Although thousands of modified sites and proteins can now be routinely, accurately, and reproducibly identified and quantified in large-scale MS-based proteomic studies, it still remains challenging to pinpoint the key drivers in the process of interest 22 . IMPA offers an original solution to this current dilemma. The integration of five different PTM-proteome layers of information allowed us to restrict the number of candidates regulated in an EGFR-ligand-specific manner from 7,053 identified proteins to 30 EGF-and 15 TGF-α-specific proteins that were regulated at multiple levels (Fig. 2) . Our analysis might not reach the same depth in terms of the number of identified proteins or modified sites as an analysis obtained when considering a single layer of information 32, 45, 46 . However, we covered close to 80% of the known HeLa proteome without using any biochemical method for boosting the number of identifications, such as treatment with phosphatase or proteasome inhibitors 45, 46 . Furthermore, by manipulating RAB7 phosphorylation and RCP levels, we were able to convert one ligand-specific response to the response associated with another ligand, and vice versa, thus underscoring the power of our methodology. Therefore, including a multilayered proteomics workflow in routine experimental design, in addition to the analysis of spatiotemporal regulation of signaling 9 and of PTM cross-talk 38 , should prove to be a powerful means of quantifying differences in intracellular responses and solving cell-signaling conundrums.
Our findings support the hypothesis that each ligand-RTK pair has developed its own regulatory mechanism for the control of receptor trafficking and downstream events. Therefore, findings on EGFR-dependent regulation of signaling cannot necessarily be generalized to all the other RTKs or even all ligands. For instance, FGF10 induces FGFR2b recycling by promoting the recruitment of SH3BP4 to the FGFR2b-PI3K complex 9 , and GGA3 binding to c-Met is necessary for receptor recycling 10 , whereas TGF-α-mediated EGFR recycling requires the binding of RCP to the receptor (Fig. 6) . In contrast with data reporting enhanced pH sensitivity of TGF-α binding to EGFR, thereby promoting early dissociation of TGF-α from the receptor in early endosomal compartments 16 , we showed that EGFR is still active during TGF-α-mediated trafficking (Supplementary Fig. 1) . Preserving a minimal kinase activity of EGFR after ligand dissociation might result in sufficient RCP binding to drive receptor intracellular fate. Our data clearly indicate that RTK endocytic sorting for recycling depends on the recruitment of specific adaptors, thus ultimately affecting biological outputs, e.g., cell proliferation and migration [7] [8] [9] [10] . Our findings suggest not only that recycling is an actively regulated process that affects long-term responses but also that the manipulation of trafficking of certain RTKs might affect signaling outputs.
Our data also suggest that EGFR ubiquitination is not the only determinant of receptor degradation via the ESCRT-0, ESCRT-I, and ESCRT-II complexes 47 because EGF-induced RAB7 phosphorylation on Y183 is key to degradation (Fig. 5) . Furthermore, EGFR is also ubiquitinated after TGF-α stimulation, although TGF-α does not induce 0  24  72  24  72  0  24  72  24  72  0  24  72  24  72  0  24  72  24  72   RCP  RCP   0  24  72  24  72  0  24  72  24  72  24  72  24  72  0  24  72  24 r e s o u r c e the phosphorylation of HRS, which is required for EGFR degradation 44 ( Supplementary  Fig. 7) . Interestingly, TGF-α stimulation appears to induce more sustained Lys63 ubiquitination of EGFR ( Supplementary  Fig. 7) , which may in turn result in lysosomal degradation, signaling, receptor trafficking or protein-protein interactions 48 . It is still unclear whether this increase in EGFR ubiquitination in the presence of TGF-α correlates with increased receptor recycling, as has been suggested for CCR7 (ref. 49) or whether recycling is a consequence of ubiquitination (for example, due to association with differentially localized Lys63-specific DUBs). The intriguing hypothesis that EGFR trafficking-and possibly other biological processes-are regulated by a more complex and dynamic cross-talk between PTMs than anticipated is fascinating and requires further study. For instance, whether EGF-and TGF-α-dependent RAB7 phosphorylation and RCP interaction with the receptor occur at low EGF concentrations (1-2 ng/mL), below the level of detection in our experimental conditions, will be highly valuable for understanding the EGFR system in tissues in which EGFR-ligand concentrations are low, and the receptor endocytosis occurs in a clathrin-dependent manner as opposed to a clathrin-independent one (as occurs under high EGF concentrations) 28 . Because perturbations in the RTK trafficking machinery have been associated with cancer progression 12 , building an atlas of endocytic proteins specifically regulated by each ligand-RTK pair (for example, via multilayered proteomics) may pave the way for targeted intervention in human cancer. In the context of EGFR signaling, TGF-α deregulation has been associated with aggressive tumors, especially breast cancer, in which its expression is controlled by estrogen 30 . Given that the TGF-α-dependent EGFR-RCP-GRB2 complex is central for sustained signaling activation and cell migration (Figs. 6 and 7) , a possible therapeutic scenario in breast and perhaps other cancers might be to selectively target this complex or TGF-α responses. This idea is supported by the observations that: (i) RCP is highly expressed in estrogen-receptor-positive breast tumors and specifically controls breast cancer cell migration 50 ;
(ii) migration mediated by both TGF-α and integrin, but not EGF, depends on RCP and recycling in general 34 (Fig. 7) ; (iii) TGF-α signaling is sustained, and signaling dynamics is now considered to be pharmacologically modifiable 51 ; (iv) TGF-α induces a unique signature of ubiquitinated and phosphorylated proteins regulating not only signaling and endocytosis but also long-term processes, such as transcription, DNA replication or damage, and proliferation. This finding suggests the possibility of fine-tuning TGF-α signaling with surrogate ligands, as has successfully been done for EpoR 52 , to attenuate such cellular responses.
In conclusion, the multilayered proteomics approach described here has the potential to improve understanding of RTK functional selectivity 53 , offering a defined wealth of new candidates for hypothesis generation. In a broader perspective, this approach might guide individualized medicine when integrated with data from other 'omics' studies 54 .
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The MS proteomics data have been deposited in the ProteomeXchange consortium 55 via the PRIDE partner repository under data set identifier PXD003523 (multilayered proteomics of EGFR signaling) and PXD001996 (RAB7-GFP data set; multilayered proteomics of EGFR signaling_RAB7). Figures 2e,f, 3e,f, 5e , and 6b,h, and Supplementary Figure 7a,b,g,h. K.T.G.R. contributed to data analysis shown in Figures 2c, 3a-d, 4, 6a,c, and 7a, and Supplementary Figures 2-4 . J.O.S. performed the proteome experiment described in Figures 2c and 7a, and Supplementary  Figure 2a . G.C. prepared the RAB7-mutant construct. A.-K.P. performed the experiments shown in Supplementary Figure 1a, and Figures 6a,b and 2g . Figure 8 Model of EGFR trafficking, signaling, and responses, based on this study. Left, early interaction among RCP, RAB5, and RAB11 (Fig. 6h) . Right, orange arrow indicates the EGFR-mediated phosphorylation of RAB7. Ubi, ubiquitin. npg intensity distribution within the colocalization region (range ±1, where 0 = pixels distributed in a cloud with no preferential direction). We also used an objectbased method to evaluate the colocalization of EGFR with GFP-tagged proteins 56 ( Fig. 1d and Supplementary Fig. 1b) . After anisotropic diffusion filtering for noise removal, pixel intensities of each image were normalized to a range between 0 and 1, and contrast was increased to remove background by histogram equalization with custom-developed Matlab 8.6 programming language. The green channel was subjected to the automatic threshold Otsu method, thus producing a binary image. The latter was used to create masks over the red channel, thus highlighting only the endosome regions. Various colocalization parameters along with correlation values were computed within endosome regions between the green and the red channel. Colocalization performance was evaluated by Spearman´s correlation coefficient along with P values for testing the hypothesis of no correlation. Mann-Whitney U tests were used for the analysis of the entire data set, and Cohen´s distance was used to compare difference in colocalization among four replicates to avoid effect sizes.
AUTHOR COnTRIBUTIOnS M.P. performed the experiments shown in
Sample preparation for mass spectrometry. Sequential enrichment of posttranslational modifications (PTMs). HeLa cells from the three SILAC conditions were lysed at each time point in modified RIPA buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 1 mM EDTA, 5 mM β-glycerolphosphate, 5 mM sodium fluoride, and 1 mM sodium orthovanadate) supplemented with one Complete protease-inhibitor-cocktail tablet (Roche) and N-ethylmaleimide to block cysteine-based proteases such as deubiquitinases (Sigma). Because we were mainly interested in cytoplasmic/plasma membrane early signaling, we performed cell lysis in mild conditions and discarded the chromatin pellet, which is usually enriched in highly ubiquitinated proteins. Lysates were prepared as previously described 9 before peptide purification with reversed-phase Sep-Pak C18 cartridges (Waters) and elution with 50% acetonitrile. Ubiquitinated peptides were enriched as described previously 57 , fractionated with microcolumn-based strong cation exchange (SCX) chromatography as described previously 58 , and eluted at increasing pH. The supernatant from ubiquitin-enriched immunoprecipitates was kept on ice for subsequent enrichment of phosphorylated tyrosine peptides, performed as previously described 59 . The supernatant containing phosphotyrosine-enriched peptides was further enriched for phosphoserine-and phosphothreonine-containing peptides, with Titansphere chromatography, as described previously 59 .
Pulldowns. After stimulation and lysis as described above, SILAC-labeled HeLa cell lysates (10 mg for each SILAC condition) were precleared with anti-rabbit and mouse IgG (Sigma-Aldrich), supplemented with Protein G-Sepharose beads (Invitrogen) and inversion rotated for at least 4 h at 4 °C. After centrifugation at 1,000g for 5 min, cleared samples were incubated with anti-EGFR antibodies overnight at 4 °C. Protein G-Sepharose beads were added for 1 h at 4 °C, and the immunoprecipitated proteins were washed five times with ice-cold lysis buffer. For the interactome analysis of RAB7, 5 mg of proteins for each SILAC condition were treated in parallel and subjected to preclearing steps as described above. Cleared samples were then incubated with GFP-trap beads (Invitrogen) for 2 h at 4 °C. Eluates were then combined and resolved on SDS-PAGE and in-gel digested with trypsin as described 60 .
Proteome analysis. SILAC-labeled cells were lysed at 4 °C in modified RIPA buffer. 50 µg protein from each SILAC condition was mixed before SDS-PAGE and in-gel digested with trypsin.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Peptides from all samples were concentrated and desalted on C 18 StageTips as described previously 61 and analyzed with an EASY-nLC system (Thermo Fisher Scientific) connected to a Q Exactive, a LTQ-Orbitrap Velos (for samples shown in Supplementary Fig. 4a-d) or a Q-Exactive Plus (for RAB7 interactome analysis shown in Supplementary Fig. 4e-g ) mass spectrometers (both from Thermo Fisher Scientific) through a nanoelectrospray ion source. Peptides were separated on a 15-cm analytical column (75-µm inner diameter) in-house packed with 1.9 µm reversed-phase C18 beads (Reprosil-Pur AQ, Dr. Maisch) with 80-min gradients (for ubiquitinated peptides, EGFR interactome, proteome analysis) or 135-min gradients (for phosphorylated peptides analysis and RAB7 interactome analysis). The instruments were operated in data-dependent acquisition mode with settings as previously described 62 .
Raw MS data analysis. Raw data were analyzed with the MaxQuant software suite 63 , either version 1.0.14.7 with the MASCOT search engine (v. 2.3.02) (EGFR interactor analysis) or version 1.1.2.7 (analysis shown in Supplementary Fig. 4 ), 1.3.10.9 (ubiquitinated and phosphorylated peptides) and 1.4.1.4 (proteome and RAB7 interactome analysis) with the integrated Andromeda search engine 64 . Proteins were identified with parameters previously decribed 9 .
Data analysis. For the analysis of ubiquitinated and phosphorylated peptides, only peptides with a site-localization probability of at least 0.75 (ref. 26) (class I, shown in Supplementary Tables 1, 2 and 6) were included in the bioinformatics analyses. The ratios of identified and quantified modified sites were normalized to the ratio of EGFR at 1 min after stimulation with EGF or TGF-α with the unmodified peptides to account for uneven efficiency during individual experiments performed in parallel. To identify regulated modification sites, we compared the distributions of the ratio of all quantified modified peptides with all unmodified peptides that specified our technical variance, and sites with a SILAC ratio higher than 2 or lower than 0.5 were considered to be regulated. Each time point was considered to be an independent experiment, and we defined a site as regulated if its SILAC ratio was higher than 2 or lower than 0.5 in at least one experimental condition (after EGF or TGF-α stimulation for one of the time points in one of the replicates). We considered proteins to be TGF-α-dependent EGFR interactors if their TGF-α/EGF SILAC ratio at each time point was higher than 2. We considered proteins to be EGF-dependent EGFR interactors if their TGF-α/EGF SILAC ratios at time points between 1 and 40 min (when EGFR was still present and not degraded) were lower than 0.5. Therefore, our definition of regulated sites (either up-or downregulated) was quite broad. This allowed the best comparison of the two dynamic responses described here. The definition of ligand-specific EGFR interactors takes into account the total level of EGFR at each time point. Counting of different protein categories was based on this definition (Figs. 2b,c,  3a, 4a,b, and 6b, and Supplementary Figs. 1e-h and 3) . To visualize the temporal regulation of modified sites (Supplementary Figs. 3 and 5a) , heat maps of the log 2 of the EGF or TGF-α ratios were created with R software.
For unsupervised cluster analysis of the data, the log 2 ratios of all phosphorylation and ubiquitination sites that showed a ratio at all the time points were z-scored (by subtracting the mean and dividing by the s.d.) and subjected to clustering with the fuzzy c-means algorithm in GProX 1.1.12., by requesting six clusters with a fuzzification parameter of 2 and 100 algorithm iterations 65 . Subsequently, all GO biological-process terms that occurred at least five times in a cluster were tested for enrichment in the cluster compared with the group of nonregulated sites (cluster 0, static sites) by Fisher's exact test. GO terms with a P value below 0.05 after correction for multiple testing by the BenjaminiHochberg method were regarded as significantly enriched.
The S score was calculated as previously described 35 . To identify the biological functions associated with different ranges of S scores, the modified sites were divided into quintiles on the basis of their attained S scores. Subsequently, Fisher's exact test was used to extract, for each quintile, the GO biological-process terms that were enriched as compared with the sites in the remaining four quintiles. Only GO terms occurring at least three times in a quintile were included in the analysis, and a P-value threshold of 0.05 after correction for multiple testing by the Benjamini-Hochberg method was used (Supplementary Fig. 2c) .
The overview of proteins was manually curated on the basis of either STRING database 66 and visualized in Cytoscape (version 3.1). Clusters represented in Figure 4e were obtained with the Cytoscape plug-in ClusterONE. PCA was performed with Perseus software (http://www.coxdocs.org/). For identification of potential kinase motifs, the sequence windows of the regulated phosphorylation sites were compared with those of the nonregulated sites with the IceLogo resource 67 with default parameters.
For interactome and proteome data, protein-sequence coverage of at least 5% was required. Proteins recruited to RAB7 and its mutant with SILAC ratios higher than 2 or lower than 0.5 in at least one condition were considered to be 'regulated' interactors. In the EGFR data set, ratios of identified interactors were normalized to the ratio of EGFR after 1-min stimulation with each ligand, to account for uneven efficiency during individual pulldowns performed in parallel. From the 855 identified proteins, all contaminants, ribosomal, and proteasomal proteins were filtered, thus resulting in 278 proteins. Proteins with a SILAC ratio quantified at at least two time points (dynamic interactors) are shown in npg Supplementary Table 3 (list of 41 proteins) . The overview of these 41 EGFR dynamic interactors (shown in Fig. 6 ) was based on the STRING database, and the color code was based on the difference in the regulation between the two stimuli. An interactor was defined as 'stimulus regulated' if it had either a TGF-α/ EGF ratio >2 after 90-min stimulation or a TGF-α/EGF or EGF/ TGF-α/ratio >2 at one of the other time points. This criterion was based on the EGFR levels at the different time points.
For the analysis of the late proteome, proteins showing significant changes in abundance (P <0.05, significance B test) were referred to as 'regulated' (Supplementary Table 4) . The columns 'significance B' and 'significance B -BH adjusted P values' report values calculated by Perseus software 63 before and after correction for multiple testing by the Benjamini-Hochberg method, respectively. GO analysis shown in Figure 7a was performed with DAVID 68 . Significantly overrepresented GO terms within the proteome data were represented in bar plots.
For the Venn diagram shown in Figure 2c , we collected in Supplementary Table 5 the 7,053 nonredundant accession codes found in the 'UniProt protein ID' columns in Supplementary Tables 1-4 . All counts of regulated proteins were based on this gene-centric table. We estimated the phosphorylation site occupancy on the basis of regulated phosphopeptide SILAC ratios, as previously described 43 .
Statistical analysis.
The SILAC experiments were performed in duplicate. All the other experiments were performed in at least triplicate. Results shown are mean ± s.d. or ± s.e.m., and P values were calculated with Student's two-tailed t tests, Wilcoxon tests with an alpha of 0.05, or Fisher's exact tests, as indicated. In Figure 2f , P values were calculated with a two-sample Student's t test on slopes calculated by the linear least-squares regression model. Bonferroni correction was used to correct for multiple t-test comparisons. A statistically significant difference was concluded when P < 0.05, P < 0.02 or P < 0.01, as indicated by asterisks in the figures and as reported in the figure legends.
